22Figure 22.1 The impact of time. Survival curves of patients based on time pe...Figure 22.2 Survival curve of patients who received novel therapies compared...Figure 22.3 Progression‐free survival stratified by consolidative strategy. ...Figure 22.4 Meta‐analysis of the hazard ratios of overall survival in patien...17 Chapter 26Figure 26.1 (A) Overall survival of patients with the common subtypes of per...Figure 26.2 Five‐year survival rates in different histological subtypes from...
18 Chapter 28Figure 28.1 Organizational structure of the the Global T‐cell Lymphoma Conso...Figure 28.2 Clinical trial concept evaluation.Figure 28.3 Safety reporting for the Global T‐cell Lymphoma Consortium (FDA,...
Guide
1 Cover
2 Table of Contents
Pages
1 iii
2 iv
3 xix
4 xx
5 xxi
6 xxii
7 xxiv
8 1
9 3
10 4
11 5
12 6
13 7
14 8
15 9
16 10
17 11
18 12
19 13
20 14
21 15
22 16
23 17
24 18
25 19
26 20
27 21
28 22
29 23
30 24
31 25
32 26
33 27
34 28
35 29
36 30
37 31
38 32
39 33
40 34
41 35
42 36
43 37
44 38
45 39
46 40
47 41
48 42
49 43
50 44
51 45
52 47
53
